Cholesterol management in US adults with ASCVD in the Family Heart Database® during 2022–23: Current state of care and opportunities for improvement
In this cohort of 3.6 million US adults with ASCVD there was a substantial gap between guideline recommended LDL-C management and clinical care. Several factors contributed to this gap including low use of nonstatin LDL-C therapies in this high-risk population.
Authors
- Laurence S. Sperling (ORCID: https://orcid.org/0000-0001-9417-6370)
- Katherine Wilemon (ORCID: https://orcid.org/0000-0003-4629-6866)
- Diane MacDougall (ORCID: https://orcid.org/0009-0004-7332-4185)
- Keith C. Ferdinand (ORCID: https://orcid.org/0000-0003-3338-4410)
- Seth J. Baum (ORCID: https://orcid.org/0000-0003-1202-8126)
- Steven E. Nissen
- Bonnie Hartsuff
Institutions
- Tulane University (US)
- Cleveland Clinic (US)
- Emory University (US)
- Flex (United States) (US)
- Heart Foundation (US)
- Ann Arbor Center for Independent Living (US)
Publication Details
- Journal
- American Journal of Preventive Cardiology
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1016/j.ajpc.2025.101354
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00